生物谷
(833266)
| 流通市值：8.79亿 | | | 总市值：11.56亿 |
| 流通股本：9427.89万 | | | 总股本：1.24亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 154,441,052.85 | 622,338,700.67 | 469,237,445.29 | 313,024,476.75 |
| 营业收入 | 154,441,052.85 | 622,338,700.67 | 469,237,445.29 | 313,024,476.75 |
| 二、营业总成本 | 143,357,725.12 | 600,685,735.41 | 450,446,448.2 | 304,607,910.31 |
| 营业成本 | 32,158,096.78 | 118,619,183.21 | 89,183,183.43 | 60,464,805.91 |
| 税金及附加 | 2,980,519.63 | 10,241,849.99 | 7,196,894.92 | 5,365,118.94 |
| 销售费用 | 91,884,232.81 | 394,867,241.35 | 301,807,936.6 | 204,605,690.54 |
| 管理费用 | 13,415,205.69 | 55,703,833.29 | 37,465,278.75 | 24,567,968.28 |
| 研发费用 | 2,782,072.88 | 20,130,564.61 | 14,670,318.64 | 9,392,894.55 |
| 财务费用 | 137,597.33 | 1,123,062.96 | 122,835.86 | 211,432.09 |
| 其中:利息费用 | 769,546.31 | 1,857,194.95 | 628,060.98 | 444,278.47 |
| 其中:利息收入 | 638,721.58 | 757,062.13 | 524,724.54 | 247,646.32 |
| 加:公允价值变动收益 | - | -2,156,773.34 | 990,000 | 990,000 |
| 加:投资收益 | - | 2,599,320.3 | 419,880.3 | 419,880.3 |
| 资产处置收益 | - | -193,493.87 | - | - |
| 资产减值损失(新) | -64,307.97 | -4,569,478.24 | -2,790,027.55 | -2,307,633.19 |
| 信用减值损失(新) | 839,036.56 | -42,094,753.68 | -19,147,230.4 | -19,939,174.09 |
| 其他收益 | 1,666,510.49 | 12,472,130.88 | 10,444,619.68 | 8,118,893.97 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 13,524,566.81 | -12,290,082.69 | 8,708,239.12 | -4,301,466.57 |
| 加:营业外收入 | 0.32 | 39.73 | 38.59 | 38.48 |
| 减:营业外支出 | 277,129.33 | 18,350.52 | 6,635.65 | 1,179.17 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 13,247,437.8 | -12,308,393.48 | 8,701,642.06 | -4,302,607.26 |
| 减:所得税费用 | 2,718,173.49 | -108,111.43 | 2,657,531.65 | -315,689.76 |
| 六、净利润 | 10,529,264.31 | -12,200,282.05 | 6,044,110.41 | -3,986,917.5 |
| 持续经营净利润 | 10,529,264.31 | -12,200,282.05 | 6,044,110.41 | -3,986,917.5 |
| 归属于母公司股东的净利润 | 10,529,264.31 | -12,200,282.05 | 6,044,110.41 | -3,986,917.5 |
| (一)基本每股收益 | 0.08 | -0.1 | 0.05 | -0.03 |
| (二)稀释每股收益 | - | -0.1 | 0.05 | -0.03 |
| 九、综合收益总额 | 10,529,264.31 | -12,200,282.05 | 6,044,110.41 | -3,986,917.5 |
| 归属于母公司股东的综合收益总额 | - | -12,200,282.05 | 6,044,110.41 | -3,986,917.5 |
| 公告日期 | 2024-04-29 | 2024-04-29 | 2023-10-27 | 2023-08-14 |
| 审计意见(境内) | | 保留意见 | | |